Texas Cannabis Legislation

HB46 expands Texas' Compassionate-Use Program for low-THC cannabis, impacting patient access and program administration.

SB3 regulated hemp products and cannabinoids, requiring licenses and creating offenses, impacting consumers and operators by restricting access and increasing oversight.

SB1870 prevents local Texas governments from creating or enforcing ordinances that prohibit or regulate consumable hemp products, impacting consumers and operators.

SB1868 adds kratom to the Texas Controlled Substances Act, creating new criminal offenses and increasing penalties, impacting consumers and the public by restricting access to a substance currently unregulated.

HB3242 reduces penalties for low-level cannabis offenses, impacting consumers and the public by lessening criminal consequences and potentially generating state revenue through fees.

HB5307 establishes a comprehensive regulatory framework for cannabis in Texas, covering everything from cultivation to taxation, and includes expunctions for past offenses.

HB28 transfers consumable hemp regulation to the Texas Alcoholic Beverage Commission, requiring registration, imposing fees, and creating criminal offenses, impacting consumers, operators, and public safety.

HB5643 criminalized certain hemp products, taxed their sale, and established a regulatory framework, impacting consumers, producers, and the state's cannabis market.

HB4242 criminalized the sale of smokable hemp products in Texas, impacting consumers and the hemp industry.

HB848 reduces penalties for possession or delivery of cannabis concentrates, potentially lessening criminalization for Texas patients and consumers.

SB2142 creates a consumable hemp products account in Texas' general revenue fund, imposing fees for manufacturer licensing and retailer registration.

HB2975 establishes a comprehensive regulatory framework for adult-use cannabis in Texas, covering cultivation to taxation, impacting consumers, operators, and public revenue.

SB1505 would have expanded qualifying conditions for low-THC cannabis under the Texas Compassionate-Use Program, impacting patient access.

SB259 expanded Texas's medical cannabis program to allow patient cultivation, broader qualifying conditions, and more licensed dispensaries, but it did not pass.

HB2972 expands Texas's low-THC medical cannabis program to include more qualifying conditions, impacting patient access and the state's cannabis market.

HB3122 creates a defense for possessing certain hemp products that might contain controlled substances or marijuana, impacting consumers and the public by clarifying legal protections.

HB1113 regulates hemp production, requires research permits, and creates a criminal offense, impacting Texas consumers, operators, and the public.

SB2028 reduces penalties for low-level cannabis possession, impacting Texans with minor offenses and potentially freeing up law enforcement resources.

SB1867 adds synthetic cannabinoids to Penalty Group 2, increasing penalties for possession and distribution in Texas.

HB1797 protects Texas state employees and contractors from adverse action for medical low-THC cannabis use, impacting patient employment rights.

HB1763 repeals cannabis offenses and regulations, potentially decriminalizing possession and expanding access for patients and consumers in Texas.

SB2952 regulates hemp and nonconsumable hemp products, increasing criminal and civil penalties, requiring occupational licenses, and imposing fees in Texas.

HB2155 prohibits the sale of consumable hemp products, criminalizing access for consumers and eliminating a market for Texas operators.

HB1750 would have legalized the processing, manufacture, and sale of smokable hemp products in Texas, expanding consumer access and market opportunities.

HB1504 would have established a comprehensive medical cannabis program in Texas, allowing patient access, cultivation, and a regulated market.

HB1574 expands Texas' low-THC medical cannabis program to include more qualifying conditions, potentially increasing patient access to therapeutic cannabis.

HB1208 establishes a comprehensive regulatory framework for cannabis in Texas, covering everything from cultivation to taxation, impacting consumers, businesses, and public revenue.

HB1146 expands Texas's Compassionate Use Program to include more qualifying conditions for low-THC cannabis, potentially increasing patient access.

HJR70 proposed a constitutional amendment to direct the legislature to authorize and regulate medical cannabis, impacting patient access and the state's regulatory framework.

SB1103 bans flavored consumable hemp products in Texas, impacting consumer choice and the market for hemp operators.

SB928 expanded the Texas Compassionate Use Program to include more qualifying conditions and allow for low-THC cannabis delivery, impacting patient access and operator logistics.

SB734 expands Texas' medical cannabis program to include more qualifying conditions, allows cultivation and broader distribution, and establishes a licensing framework for operators.

SB733 establishes a medical cannabis research program in Texas, potentially expanding patient access to new treatments and informing future policy.

SB335 establishes a comprehensive regulatory framework for cannabis in Texas, impacting patients, consumers, and businesses by legalizing and controlling the entire supply chain.

SB170 would have legalized medical cannabis for patients with certain conditions and licensed cannabis organizations in Texas.